Merck KGaA transforms life sciences R&D with a new supercomputing platform built in partnership with Lenovo and Equinix. This deep dive explores how the pharmaceutical giant is shifting from wet labs to high-performance computing to accelerate drug discovery and material science, while addressing sustainability and data sovereignty.